These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 33002549)
1. The effect of COVID-19 on Ramadan fasting in people with diabetes in East London 2020: The East London diabetes in Ramadan survey. Khan H; Chowdhury A; Lasker SS; Chowdhury TA Diabetes Res Clin Pract; 2020 Nov; 169():108476. PubMed ID: 33002549 [TBL] [Abstract][Full Text] [Related]
2. Fasting outcomes in people with diabetes and chronic kidney disease in East London during Ramadan 2018: The East London diabetes in Ramadan survey. Chowdhury A; Khan H; Lasker SS; Chowdhury TA Diabetes Res Clin Pract; 2019 Jun; 152():166-170. PubMed ID: 31150726 [TBL] [Abstract][Full Text] [Related]
3. Ramadan fasting in people with diabetes and chronic kidney disease (CKD) during the COVID-19 pandemic: The DaR global survey. Hassanein M; Yousuf S; Ahmedani MY; Albashier A; Shaltout I; Yong A; Hafidh K; Hussein Z; Kallash MA; Aljohani N; Wong HC; Buyukbese MA; Chowdhury T; Fadhila MERZOUKI; Taher SW; Belkhadir J; Malek R; Abdullah NRA; Shaikh S; Alabbood M Diabetes Metab Syndr; 2023 Jul; 17(7):102799. PubMed ID: 37301008 [TBL] [Abstract][Full Text] [Related]
4. Ramadan fasting in people with type 1 diabetes during COVID-19 pandemic: The DaR Global survey. Hassanein M; Alamoudi RM; Kallash MA; Aljohani NJ; Alfadhli EM; Tony LE; Khogeer GS; Alfadhly AF; Khater AE; Ahmedani MY; Buyukbese MA; Shaltout I; Belkhadir J; Hafidh K; Chowdhury TA; Hussein Z; Elbarbary NS Diabetes Res Clin Pract; 2021 Feb; 172():108626. PubMed ID: 33321160 [TBL] [Abstract][Full Text] [Related]
5. The DAR 2020 Global survey: Ramadan fasting during COVID 19 pandemic and the impact of older age on fasting among adults with Type 2 diabetes. Hassanein M; Hussein Z; Shaltout I; Wan Seman WJ; Tong CV; Mohd Noor N; Buyukbese MA; El Tony L; Shaker GM; Alamoudi RM; Hafidh K; Fariduddin M; Batais MA; Shaikh S; Malek PR; Alabbood M; Sahay R; Alshenqete AM; Yakoob Ahmedani M Diabetes Res Clin Pract; 2021 Mar; 173():108674. PubMed ID: 33493579 [TBL] [Abstract][Full Text] [Related]
6. Attitude and safety of patients with diabetes observing the Ramadan fast. Ba-Essa EM; Hassanein M; Abdulrhman S; Alkhalifa M; Alsafar Z Diabetes Res Clin Pract; 2019 Jun; 152():177-182. PubMed ID: 30946851 [TBL] [Abstract][Full Text] [Related]
7. Managing People with Diabetes Fasting for Ramadan During the COVID-19 Pandemic: A South Asian Health Foundation Update. Hanif S; Ali SN; Hassanein M; Khunti K; Hanif W Diabet Med; 2020 Jul; 37(7):1094-1102. PubMed ID: 32333691 [TBL] [Abstract][Full Text] [Related]
8. Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: Results of the Canagliflozin in Ramadan Tolerance Observational Study (CRATOS). Hassanein M; Echtay A; Hassoun A; Alarouj M; Afandi B; Poladian R; Bennakhi A; Nazar M; Bergmans P; Keim S; Hamilton G; Azar ST Int J Clin Pract; 2017 Oct; 71(10):. PubMed ID: 28851109 [TBL] [Abstract][Full Text] [Related]
9. Higher HbA1c was observed in young people with diabetes who fasted during COVID-19 pandemic lockdown of 2020 Ramadan in Bangladesh - A Post Ramadan survey. Zabeen B; Ahmed B; Nahar J; Tayyeb S; Islam N; Mohsin F; Azad K Diabetes Res Clin Pract; 2022 Apr; 186():109812. PubMed ID: 35301071 [TBL] [Abstract][Full Text] [Related]
10. Knowledge of diabetes mellitus and safe practices during Ramadan fasting among Muslim patients with diabetes mellitus in Singapore. Zainudin SB; Ang DY; Soh AW Singapore Med J; 2017 May; 58(5):246-252. PubMed ID: 27121922 [TBL] [Abstract][Full Text] [Related]
11. Patient perspectives on type 2 diabetes and medicine use during Ramadan among Pakistanis in Denmark. Mygind A; Kristiansen M; Wittrup I; Nørgaard LS Int J Clin Pharm; 2013 Apr; 35(2):281-8. PubMed ID: 23354808 [TBL] [Abstract][Full Text] [Related]
12. Patterns of Diabetes Care Among People with Type 1 Diabetes During Ramadan: An International Prospective Study (DAR-MENA T1DM). Al Awadi FF; Echtay A; Al Arouj M; Sabir Ali S; Shehadeh N; Al Shaikh A; Djaballah K; Dessapt-Baradez C; Omar Abu-Hijleh M; Bennakhi A; El Hassan Gharbi M; El Sayed El Hadidy K; Abdul Kareem Khazaal F; Hassanein MM Adv Ther; 2020 Apr; 37(4):1550-1563. PubMed ID: 32144714 [TBL] [Abstract][Full Text] [Related]
13. Risk Stratification, Intention to Fast, and Outcomes of Fasting During Ramadan in People With Diabetes Presenting to a Tertiary Care Hospital. Malik SE; Kanwal S; Haider I; Iqbal Y; Naeem H; Jehandad Z; Javed J; Shah SA Endocr Pract; 2024 Oct; 30(10):951-956. PubMed ID: 38969009 [TBL] [Abstract][Full Text] [Related]
14. The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial. Al Sifri S; Basiounny A; Echtay A; Al Omari M; Harman-Boehm I; Kaddaha G; Al Tayeb K; Mahfouz AS; Al Elq A; Radican L; Ozesen C; Katzeff HL; Musser BJ; Suryawanshi S; Girman CJ; Davies MJ; Engel SS; Int J Clin Pract; 2011 Nov; 65(11):1132-40. PubMed ID: 21951832 [TBL] [Abstract][Full Text] [Related]
15. Verification of 2021 IDF-DAR risk assessment tool for fasting Ramadan in patients with diabetes attending primary health care in The Kingdom of Bahrain: The DAR-BAH study. Shamsi N; Naser J; Humaidan H; Al-Saweer A; Jaafar M; Abbas F; Al-Doseri S; Shabeeb N; Al-Shaikh E; Al-Dairi A; Mandoos K Diabetes Res Clin Pract; 2024 May; 211():111661. PubMed ID: 38604445 [TBL] [Abstract][Full Text] [Related]
16. An update on the current characteristics and status of care for Muslims with type 2 diabetes fasting during Ramadan: the DAR global survey 2022. Hassanein M; Binte Zainudin S; Shaikh S; Shaltout I; Malek R; Buyukbese MA; Alfadhli EM; Shaikh K; Hussein Z; Eliana F; Hafidh K; El Toony LF; Fariduddin M; Alabbood M; Batais MA; Akter N; Rosandi R; Odhaib SA; Al Amoudi R; Ahmedani MY Curr Med Res Opin; 2024 Sep; 40(9):1515-1523. PubMed ID: 39076065 [TBL] [Abstract][Full Text] [Related]
17. Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study. Aravind SR; Ismail SB; Balamurugan R; Gupta JB; Wadhwa T; Loh SM; Suryawanshi S; Davies MJ; Girman CJ; Katzeff HL; Radican L; Engel SS; Wolthers T Curr Med Res Opin; 2012 Aug; 28(8):1289-96. PubMed ID: 22738801 [TBL] [Abstract][Full Text] [Related]
18. A survey of fasting practices and acceptance of an intervention for achieving control in diabetes during Ramadan. Dabral S; Mukherjee S; Saha N; Manjavkar S; Kohli S Natl Med J India; 2020; 33(1):5-9. PubMed ID: 33565478 [TBL] [Abstract][Full Text] [Related]
19. CREED study: Hypoglycaemia during Ramadan in individuals with Type 2 diabetes mellitus from three continents. Jabbar A; Hassanein M; Beshyah SA; Boye KS; Yu M; Babineaux SM Diabetes Res Clin Pract; 2017 Oct; 132():19-26. PubMed ID: 28783529 [TBL] [Abstract][Full Text] [Related]
20. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Salti I; Bénard E; Detournay B; Bianchi-Biscay M; Le Brigand C; Voinet C; Jabbar A; Diabetes Care; 2004 Oct; 27(10):2306-11. PubMed ID: 15451892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]